Direct-to-consumer Genetic Testing Market to exceed $ 1990 Mn by 2024

September 24, 2019


According to the latest research report available at MarketStudyReport.com under the title ‘Global Direct-to-consumer Genetic Testing Market Growth (Status and Outlook) 2019-2024’, the worldwide direct-to-consumer genetic testing market is anticipated to surpass US $1990 million by the year 2024.
 

Direct-to-consumer (DTC) genetic testing is a kind of gene-related test that is available directly to the end-user without going through a medical professional. Generally, doctors and health care professionals get their patient’s permission and order the required genetic test. Direct-to consumer genetic tests, however, permit users to bypass the medical professionals and order DNA tests independently.
 

According to the report, DTC genetic testing market is analyzed as per product type, application spectrum and regional landscape. Based on product type, the market is segmented as relationship testing, diagnostic screening, and newborn screening, pre-implementation & parental diagnosis. While based on application spectrum, the market is fragmented as online and offline.
 

The worldwide direct to consumer genetic testing market was worth US $930 million in 2019 and is predicted to register growth with a CAGR of 16.4% over the forecast period. The report also studies the DTC genetic testing market comprehensively to understand the drivers, challenges, opportunities, and trends affecting the market growth.
 

DTC genetic testing market is bifurcated into four major geographical regions. The U.S., Canada, Mexico, and Brazil fall under Americas; Asia Pacific consists of India, China, Japan, Southeast Asia, Australia, and Korea; Germany, UK, Italy, France, Russia, and Spain comprise Europe; and Egypt, Israel, South Africa, Turkey and GCC countries constitute Middle East & Africa.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1789966/
 

The prominent companies operating in DTC genetic testing market include Full Genomes, 23andMe, Mapmygenome, MyHeritage, Shuwen Health Sciences, LabCorp, DNA Services of America, Myriad Genetics, Genetic Health, Ancestry.com, 23 Mofang, Quest Diagnostics, Test Me DNA, Gene By Gene, Alpha Biolaboratories, DNA Diagnostics Center, DNA Family Check, lnvitae, Canadian DNA Services, IntelliGenetics, African Ancestry, Ambry Genetics, Anglia DNA Services, Living DNA, Color Genomics, Easy DNA, Xcode, Pathway Genomics, and Centrillion Technology.